September 18th 2024
The FDA has approved the Eversense 365, the world’s first 1-year continuous glucose monitor, with US availability expected in late 2024.
Updated Recommendations for Gestational Diabetes Streamline Screening Methods
June 16th 2014In response to the growing prevalence of gestational diabetes mellitus and its associated morbidities, much attention has been paid to the use of appropriate screening methodologies for the metabolic disorder.
Novel Orally Available GLP-1 Agonist Lowers HbA1c in Patients with Type 2 Diabetes
June 16th 2014Study results show that an alternative to currently-marketed injectable agents retains the efficacy of GLP-1 mimetics, while reducing gastrointestinal adverse events and providing the convenience of oral dosing.
Concentrated Formulation of Insulin Glargine Shows Improved Management of Type 2 Diabetes
June 15th 2014Patients treated with a new, more concentrated insulin glargine formulation experienced similar glycemic control with fewer nocturnal and daytime hypoglycemic events compared with patients treated with the current formulation of the product.
Basal Insulin Therapy with Glargine Biosimilar Meets Non-Inferiority Criteria
June 15th 2014Study results presented at ADA 2014 show Eli Lilly's investigational long-acting basal insulin analog to have similar clinical efficacy in reducing HbA1c levels as a currently approved injectable insulin glargine product, with a comparable side effect profile.
What's the Story with Testosterone Replacement Therapy and Diabetes?
Just weeks after Australian researchers published data suggesting that testosterone replacement therapy does not ameliorate type 2 diabetes among hypogonadal men, a team of American researchers has unveiled a second study that suggests just the opposite.
Painful Buttock Lesion in a Pregnant Woman
May 21st 2014A 36-year-old pregnant woman at 27 weeks gestation presented to the obstetrical triage for evaluation of possible abscess due to a lesion on her buttock that first appeared 1 week ago. Since that time, it has become increasingly painful and itchy. Although she denies any systemic symptoms, her pregnancy is complicated by gestational diabetes and obesity. However, she is HIV negative and her other prenatal labs were unremarkable.
Continuous Intraperitoneal Insulin Demonstrates Long-term Effectiveness in Type 1 Diabetes
May 14th 2014Despite intensive subcutaneous insulin therapy, a relatively small group of type 1 diabetics fails to reach adequate glycemic control, has frequent hypoglycemic episodes, or develops insulin resistance.
Recognizing MRSA Infection Risk in Diabetic Foot Ulcers
May 13th 2014Since nearly half of all Staphylococcus aureus infections harbor difficult-to-cure methicillin-resistant (MRSA) isolates, identifying MRSA risk factors could improve infection prevention and treatment, as well as reduce resistance patterns.